Khalid Zoghebi

878 total citations
40 papers, 534 citations indexed

About

Khalid Zoghebi is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Khalid Zoghebi has authored 40 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Biomaterials and 4 papers in Genetics. Recurrent topics in Khalid Zoghebi's work include RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Phytochemicals and Antioxidant Activities (4 papers). Khalid Zoghebi is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Phytochemicals and Antioxidant Activities (4 papers). Khalid Zoghebi collaborates with scholars based in Saudi Arabia, India and United States. Khalid Zoghebi's co-authors include Asim Najmi, Hassan A. Alhazmi, Muhammad Naeem‐ul‐Hassan, Hatem M.A. Amin, Nasir Assad, Azhar Abbas, Mohammed Al Bratty, Ali Hanbashi, Keykavous Parang and Hafiz A. Makeen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Molecules.

In The Last Decade

Khalid Zoghebi

31 papers receiving 524 citations

Peers

Countries citing papers authored by Khalid Zoghebi

Since Specialization

Citations

This map shows the geographic impact of Khalid Zoghebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Zoghebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Zoghebi more than expected).

Fields of papers citing papers by Khalid Zoghebi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Zoghebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Zoghebi. The network helps show where Khalid Zoghebi may publish in the future.

Co-authorship network of co-authors of Khalid Zoghebi

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Zoghebi. A scholar is included among the top collaborators of Khalid Zoghebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Zoghebi. Khalid Zoghebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural insights into PKS13 Thioesterase inhibitors targeting Mycobacterium tuberculosis for drug-resistant tuberculosis therapy: Identification, stability assessment, and pharmacophore modeling 2025 ·Results in Chemistry ·Zia Ur Rehman, Hassan A. Alhazmi, Mohammed Albratty, Abdullah Algaissi, Hafiz A. Makeen, Asim Najmi, Khalid Zoghebi, Sivakumar S. Moni, (unknown), Manal Mohamed Elhassan Taha, (unknown), (unknown), (unknown)	1
2	Effect of Pinus radiata extract on the properties and performance of sodium alginate and kappa-carrageenan composite films 2025 ·Polymer Bulletin ·(unknown), Muhammad Jawad, (unknown), Sampath Chinnam, Ahmed Al‐Harrasi, Esra Koca, Levent Yurdaer Aydemir, Tanveer Alam, Syam Mohan, Khalid Zoghebi, Asaad Khalid	0
3	Exploring the anti-cancer properties of Carissa carandas as a multi-targeted approach against breast cancer 2024 ·Journal of Biomolecular Structure and Dynamics ·Khalid Zoghebi, Fahad Y. Sabei, Awaji Y. Safhi	0
4	Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges 2024 ·Frontiers in Immunology ·Sadique A. Javed, Asim Najmi, Waquar Ahsan, Khalid Zoghebi	43
5	Preparation and characterization of gelatin‐pectin‐based active films incorporated with Styrax benzoin oleo gum resin 2024 ·Polymers for Advanced Technologies ·Saurabh Bhatia, Muhammad Jawad, Sampath Chinnam, Ahmed Al‐Harrasi, Yasir Abbas Shah, Esra Koca, Levent Yurdaer Aydemir, Tanveer Alam, Syam Mohan, Khalid Zoghebi, Asaad Khalid	1
6	Integrating network pharmacology with molecular docking to rationalize the ethnomedicinal use of Alchornea laxiflora (Benth.) Pax & K. Hoffm. for efficient treatment of depression 2024 ·Frontiers in Pharmacology ·(unknown), Mukul Tailang, (unknown), (unknown), Neelaveni Thangavel, Hafiz A. Makeen, Mohammed Albratty, Asim Najmi, Hassan A. Alhazmi, Khalid Zoghebi, M Alagusundaram, (unknown)	20
7	Computational insights into KRAS G12C inhibition: exploring possible repurposing of Azacitidine and Ribavirin 2024 ·Journal of Biomolecular Structure and Dynamics ·Vishakha Sharma, (unknown), Ravi Rawat, Monica Gulati, Tapan Behl, Asaad Khalid, Asim Najmi, Khalid Zoghebi, (unknown), Syam Mohan	1
8	Cardioprotective Potential of Bioactive Compound from Methanolic Extract of Asparagus racemosus : An in silico Study Utilizing GC–MS Analysis 2024 ·Pharmacognosy Magazine ·(unknown), (unknown), N. Kannappan, Khalid Zoghebi, Mohammed Albratty, Hassan A. Alhazmi, Asim Najmi, Md Shamsher Alam	0
9	Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management 2023 ·Cellular Signalling ·Shriyansh Srivastava, (unknown), Sachin Kumar, Pramod Kumar Sharma, Tapan Behl, Asaad Khalid, Syam Mohan, Asim Najmi, Khalid Zoghebi, Hassan A. Alhazmi	27
10	From inflammation to metastasis: The central role of miR-155 in modulating NF-κB in cancer 2023 ·Pathology - Research and Practice ·Syam Mohan, Mohammed Ageeli Hakami, Hamad Ghaleb Dailah, Asaad Khalid, Asim Najmi, Khalid Zoghebi, (unknown), (unknown)	5
11	Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1 2023 ·Pathology - Research and Practice ·Syam Mohan, Mohammed Ageeli Hakami, Hamad Ghaleb Dailah, Asaad Khalid, Asim Najmi, Khalid Zoghebi, (unknown)	4
12	Statistically Optimized Polymeric Buccal Films of Eletriptan Hydrobromide and Itopride Hydrochloride: An In Vivo Pharmacokinetic Study 2023 ·Pharmaceuticals ·Awaji Y. Safhi, (unknown), Muhammad Zaman, Rai Muhammad Sarfraz, (unknown), Asif Mahmood, Ahmad Salawi, Fahad Y. Sabei, (unknown), Khalid Zoghebi	3
13	Improved Photocatalytic and Antioxidant Activity of Olive Fruit Extract-Mediated ZnO Nanoparticles 2023 ·Antioxidants ·(unknown), Azhar Abbas, Muhammad Naeem‐ul‐Hassan, Nasir Assad, Muhammad Sher, Sami Ullah, Hassan A. Alhazmi, Asim Najmi, Khalid Zoghebi, Mohammed Al Bratty, Ali Hanbashi, Hafiz A. Makeen, Hatem M.A. Amin	109
14	Daidzein from Dietary Supplement to a Drug Candidate: An Evaluation of Potential 2023 ·ACS Omega ·(unknown), (unknown), (unknown), (unknown), Mohammed Albratty, Hafiz A. Makeen, Hassan A. Alhazmi, Asim Najmi, Khalid Zoghebi, (unknown), Abuzer Ali, Md Shamsher Alam, Zeenat Iqbal, Mohd. Aamir Mirza	26
15	A highly selective Hg²⁺ colorimetric sensor and antimicrobial agent based on green synthesized silver nanoparticles using Equisetum diffusum extract 2023 ·RSC Advances ·(unknown), Azhar Abbas, Nasir Assad, Muhammad Naeem‐ul‐Hassan, Hassan A. Alhazmi, Asim Najmi, Khalid Zoghebi, Mohammed Al Bratty, Ali Hanbashi, Hatem M.A. Amin	85
16	Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents 2023 ·Pharmaceuticals ·(unknown), Khalid Zoghebi, (unknown), Lois G. Kim, (unknown), Rakesh Kumar Tiwari, Keykavous Parang	5
17	Molecular Chaperones as Therapeutic Target: Hallmark of Neurodegenerative Disorders 2023 ·Molecular Neurobiology ·Aditi Sharma, (unknown), Lalit Sharma, Monica Gulati, Tapan Behl, Asaad Khalid, Syam Mohan, Asim Najmi, Khalid Zoghebi	7
18	Virosome: An engineered virus for vaccine delivery 2023 ·Saudi Pharmaceutical Journal ·Hasan Ali, (unknown), Babar Iqbal, Faraat Ali, Neeraj Sharma, Nitin Kumar, Asim Najmi, Mohammed Albratty, Hassan A. Alhazmi, Osama A. Madkhali, Khalid Zoghebi, Md Shamsher Alam	24
19	Cyclic Peptides as Protein Kinase Inhibitors: Structure–Activity Relationship and Molecular Modeling 2021 ·Journal of Chemical Information and Modeling ·Michel F. Sanner, Khalid Zoghebi, (unknown), (unknown), Simin Rahighi, Rakesh Kumar Tiwari, Keykavous Parang	12
20	Hydrophobic interactions between the HA helix and S4‐S5 linker modulate apparent Ca²⁺ sensitivity of SK2 channels 2020 ·Acta Physiologica ·Youngwoo Nam, Meng Cui, (unknown), (unknown), (unknown), (unknown), Khalid Zoghebi, Simin Rahighi, Keykavous Parang, Miao Zhang	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact